Swiss Pharma Group S.A.
Swiss Pharma Group S.A. is a Paraguayan pharmaceutical manufacturer, founded in 2017, that operates the country's first soft gelatin capsule plant in San Lorenzo, producing nutritional supplements, OTC medications, and vaginal ovules for the Paraguayan pharmacy distribution market.
- Company typePrivate
- Founded2017
- HeadquartersSan Lorenzo, Paraguay
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Swiss Pharma Group S.A. does
Swiss Pharma Group S.A. is a Paraguayan pharmaceutical manufacturer founded in 2017 and headquartered in San Lorenzo, Paraguay, operating the country's first soft gelatin capsule (cápsulas blandas) production plant. The company runs a vertically integrated, single-facility manufacturing process covering the full softgel production chain — gelatin melting, active-ingredient encapsulation, and blister packaging — with in-house quality control at every stage and company-owned warehousing for storage and distribution. Its product portfolio spans three categories: nutritional supplements (chia oil, fish oil omega-3, krill oil/Omega K85, vitamin E, vitamin A), over-the-counter pharmaceutical forms (ibuprofen 400 mg and 600 mg, ibuprofen with caffeine, simethicone, paracetamol-based cold/flu combinations), and vaginal ovules (clindamycin, miconazole, ketoconazole, metronidazole, and combination formulations).
The company's commercial model is the in-country manufacture and sale of finished softgel and ovule products through Paraguayan pharmaceutical distributors and pharmacies. It employs 22 people, operates as a privately held 100% Paraguayan investment, and has no disclosed external investors, parent company, or funding rounds. Marketing is primarily educational, with articles published on the corporate website explaining soft-capsule composition, drug absorption, and benefits. The facility was designed from inception to comply with both domestic sanitary surveillance standards and international pharmaceutical regulations, and was built with an explicit international expansion vision, although current revenue activity remains concentrated within Paraguay.
Swiss Pharma Group S.A. firmographics
Firmographics- Name
- Swiss Pharma Group S.A.
- Legal name
- Swiss Pharma Group S.A.
- Website
- https://swisspharma.com.py
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Swiss Pharma Group S.A. is a Paraguayan pharmaceutical manufacturer, founded in 2017, that operates the country's first soft gelatin capsule plant in San Lorenzo, producing nutritional supplements, OTC medications, and vaginal ovules for the Paraguayan pharmacy distribution market.
- Ownership category
- akta.pro rank
Swiss Pharma Group S.A. industry classification
Industry- Product category
- Pharmaceutical Manufacturing (Soft Gelatin Capsules)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Swiss Pharma Group S.A. is headquartered
LocationHeadquarters
- HQ city
- San Lorenzo
- HQ country
- Paraguay
- HQ region
- Latin America
Offices1 record
Markets served
Swiss Pharma Group S.A. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical and Nutritional Supplement Sales: Manufacturing and sale of soft gelatin capsules containing pharmaceutical products and nutritional supplements including oils (Chia, Fish Omega 3, Krill), vitamins (E, A), ibuprofen formulations, and ovule medications
Distribution channels1 record
Marketing channels1 record
Swiss Pharma Group S.A. product offering
Product offeringCore offering
Swiss Pharma Group S.A. manufactures and sells soft gelatin capsules (cápsulas blandas) containing pharmaceutical products and nutritional supplements from its facility in San Lorenzo, Paraguay. Its portfolio spans nutritional supplements (chia oil, fish oil omega-3, krill oil, vitamins E and A), pharmaceutical forms (ibuprofen, ibuprofen-caffeine, simethicone, paracetamol combination cold/flu), and vaginal suppositories (ovules) for antifungal and antibacterial treatments. The company operates a vertically integrated in-house production process covering gelatin melting, encapsulation of active ingredients, and blister packaging, with quality control at every stage.
Product overview
Swiss Pharma Group S.A. is a Paraguayan pharmaceutical manufacturer specializing in soft gelatin capsule (cápsulas blandas) production. The company operates as a single-facility producer offering two main product lines: Nutritional Supplements (including chia oil, fish oil omega-3, krill oil, and vitamins E and A in softgel form) and Pharmaceutical Forms (including ibuprofen, paracetamol combinations, and vaginal suppositories). As the first soft capsule manufacturing plant in Paraguay, established in 2017, the company produces its complete range of products through a vertically integrated process from gelatin casting to encapsulation and blister packaging.
Differentiator
Problem solved
Functional benefit
Products and services
- Aceite de Chia 1000 mg Chia seed oil nutritional supplement in softgel capsule form at 1000mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Aceite de Chia con fitoesteroles Chia seed oil combined with phytosterols in softgel capsule form for cardiovascular support, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Aceite de pescado Omega 3 1000 mg Fish oil omega-3 nutritional supplement in softgel capsule form at 1000mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Omega K85 Krill oil-based omega-3 nutritional supplement in softgel capsule form, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Aceite de Krill 500 mg Krill oil nutritional supplement in softgel capsule form at 500mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Vitamina E 200 mg Vitamin E nutritional supplement in softgel capsule form at 200mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Vitamina E (d-alfa tocoferol acetato) 1000 mg Vitamin E nutritional supplement in d-alpha tocopherol acetate form at 1000mg dosage in softgel capsule, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Vitamina A hidrosoluble 50000 U.I Water-soluble Vitamin A nutritional supplement at 50,000 IU dosage in softgel capsule form, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Ibuprofeno 400 mg Ibuprofen analgesic and anti-inflammatory medication in softgel capsule form at 400mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Ibuprofeno 600 mg Ibuprofen analgesic and anti-inflammatory medication in softgel capsule form at 600mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Ibuprofeno cafeína Ibuprofen combined with caffeine in softgel capsule form for enhanced analgesic effect, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Simeticona 200 mg Simethicone anti-flatulence agent in softgel capsule form at 200mg dosage, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Paracetamol, Maleato de Clorfeniramina, Clorhidrato de Pseudoefedrina, Bromhidrato de Dextrometorfano Combination cold and flu medication in softgel capsule form containing paracetamol, chlorpheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Clindamicina 100 mg (Óvulos) Clindamycin 100mg vaginal suppository (ovule) for bacterial infections, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Clindamicina, Ketoconazol (Óvulos) Clindamycin and ketoconazole combination vaginal suppository (ovule) for mixed infections, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Metronidazol, Nistatina, Gentamicina Sulfato, Lidocaina Clorhidrato (Óvulos) Multi-agent vaginal suppository (ovule) containing metronidazole, nystatin, gentamicin sulfate, and lidocaine hydrochloride for complex vaginal infections, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Miconazol Nitrato, Lidocaína Clorhidrato, Fluocinolona Acetónido, Gentamicina Sulfato, Tinidazol (Óvulos) Comprehensive vaginal suppository (ovule) combining antifungal (miconazole nitrate, tinidazole), antibiotic (gentamicin sulfate), anti-inflammatory (fluocinolone acetonide), and anesthetic (lidocaine hydrochloride) agents, sold through pharmaceutical distributors and pharmacies in Paraguay.
- Miconazol Nitrato 200 mg (Óvulos) Miconazole nitrate 200mg vaginal suppository (ovule) for fungal infections, sold through pharmaceutical distributors and pharmacies in Paraguay.
Companies that use Swiss Pharma Group S.A.
Customer profileSegments1 record
Ideal customer profiles1 record
Swiss Pharma Group S.A. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Swiss Pharma Group S.A. partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights3 records
Swiss Pharma Group S.A. competitors and assessment
Company assessmentDirect peers
- Eurofarma: Major Brazilian pharmaceutical company with significant softgel manufacturing capabilities serving Brazil and broader Latin America. Comparable as a large LatAm pharma manufacturer producing similar OTC and supplement softgel formats.
- Procaps: Colombian pharmaceutical company and major Latin American softgel capsule manufacturer/CDMO with iCDMO services for pharma and nutraceutical clients. Direct competitor in the softgel CDMO and supplement space across LatAm.
Regional players
- Laboratorios Bagó: Major Argentine pharmaceutical company with diverse manufacturing footprint including softgels and a comparable OTC portfolio. Regional LatAm pharma peer with similar product breadth in OTC and supplements.
- Roemmers: Leading Argentine pharmaceutical manufacturer with diverse product portfolio across OTC, prescription, and supplement categories. Comparable as a LatAm pharma with similar formulation categories including softgel formats.
- Mega Labs: Latin American pharmaceutical company headquartered in Uruguay with manufacturing operations across multiple South American countries. Comparable as a regional LatAm pharma peer operating in similar OTC and supplement categories.
- Asofarma: Latin American pharmaceutical company serving multiple South and Central American markets with branded generics, OTC, and specialty pharma products. Comparable LatAm pharma peer in similar therapeutic categories.
Broad incumbents
- Catalent: Global pharmaceutical CDMO with major softgel encapsulation capabilities and broad pharma services across multiple technologies. Relevant incumbent for softgel contract manufacturing and benchmark for technology/capability.
- Bayer: Global pharmaceutical and consumer health giant with established OTC and supplement presence in Paraguay and across Latin America. Competes with Swiss Pharma on consumer health categories in the Paraguayan market.
- Sanofi: Global pharmaceutical company with significant OTC and consumer healthcare operations in Paraguay, including supplements and analgesics. Broad incumbent competitor in the Paraguayan consumer pharma market.
Emerging players
- Genomma Lab: Latin American consumer pharmaceutical company focused on OTC, personal care, and generic products distributed across the region. Comparable as a LatAm-focused branded OTC pharma peer in similar consumer health categories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Swiss Pharma Group S.A. social profiles
Digital presenceSwiss Pharma Group S.A. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Swiss Pharma Group S.A. leadership team
Management profileNumber of profiles
Swiss Pharma Group S.A. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Swiss Pharma Group S.A. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Swiss Pharma Group S.A.
What does Swiss Pharma Group S.A. do?
Swiss Pharma Group S.A. manufactures and sells soft gelatin capsules (cápsulas blandas) containing pharmaceutical products and nutritional supplements from its facility in San Lorenzo, Paraguay. Its portfolio spans nutritional supplements (chia oil, fish oil omega-3, krill oil, vitamins E and A), pharmaceutical forms (ibuprofen, ibuprofen-caffeine, simethicone, paracetamol combination cold/flu), and vaginal suppositories (ovules) for antifungal and antibacterial treatments. The company operates a vertically integrated in-house production process covering gelatin melting, encapsulation of active ingredients, and blister packaging, with quality control at every stage.
Is Swiss Pharma Group S.A. a public or private company?
Swiss Pharma Group S.A. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Swiss Pharma Group S.A. founded?
Swiss Pharma Group S.A. was founded in 2017. It employs 11 to 50 people.
Where is Swiss Pharma Group S.A. based?
Swiss Pharma Group S.A. is headquartered in San Lorenzo, Paraguay, in the Latin America region.
How does Swiss Pharma Group S.A. make money?
One revenue line is on record: pharmaceutical and Nutritional Supplement Sales.
Who are Swiss Pharma Group S.A.'s main competitors?
Direct peers on record are Eurofarma and Procaps. Regional players are Laboratorios Bagó, Roemmers, Mega Labs and Asofarma. Broad incumbents are Catalent, Bayer and Sanofi. Genomma Lab is listed as an emerging player.
Does Swiss Pharma Group S.A. have an API?
No public API is recorded for Swiss Pharma Group S.A..
What industry is Swiss Pharma Group S.A. in?
Swiss Pharma Group S.A.'s product category is Pharmaceutical Manufacturing (Soft Gelatin Capsules). Its primary akta.pro industry code is CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots), with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325412 and its SIC code is 2000.